Saturday, 18 January 2020


Anika Therapeutics is a pioneer in developing therapeutic products for tissue protection, healing and repair. These products are based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body. HA enhances joint function and coats, protects, cushions and lubricates soft tissues. HA also is present in the skin, where it supports skin structure and elasticity. With more than 20 years of experience in HA technology, Anika is recognized worldwide as a provider of premium HA products that are effective, safe and long-lasting.

Anika manufactures and distributes a diverse portfolio of HA-based products that cover a broad range of therapeutic applications. These products include:

Orthobiologics: Orthovisc®, Orthovisc® mini, and Monovisc™ used in the treatment of osteoarthritis; Hyalofast® for the treatment of chondral and osteochondral lesions, Hyalonect® for orthopaedic traumas and reconstruction procedures and Hyaloglide® a mechanical barrier for prevention or minimization of post surgical adhesions after tendon and peripheral nerve surgery;

Veterinary: Hyvisc® used in the treatment of equine osteoarthritis;

Dermal: Hyalomatrix® PA, Hyalofill® and Jaloskin® that are wound dressings and the Elevess™ family of cosmetic dermatology products for facial wrinkles, scar remediation and lip augmentation;

Ophthalmic: Amvisc®, Amvisc® Plus, Staarvisc™ II, and Optivisc™ injectable viscoelastic HA products for ophthalmic surgery;

Surgical: Incert®, an HA-based anti-adhesive for surgical applications;

and next-generation products for joint health and aesthetic dermatology based on the Company's proprietary, chemically modified HA.